GLAND - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.8

📉 GLAND shows weak momentum but strong fundamentals and volume support. Suitable for cautious intraday trades near support zones.

🔍 Positive

• EPS of ₹70.2 and P/E of 27.2 are attractive compared to industry average (33.1).
• ROCE (15.8%) and ROE (11.6%) reflect solid operational efficiency.
• Debt-free status (0.00 debt-to-equity) supports financial strength.
• Volume (4.63L) is well above 1-week average (2.75L), showing strong intraday interest.
• FII holding increased by 0.51%, indicating foreign investor confidence.

⚠️ Limitation

• MACD negative (-7.55) and RSI at 45.2 suggest weak momentum.
• Current price below 50 DMA (₹1,933) implies short-term bearish bias.
• PEG ratio of -7.92 suggests poor growth valuation.

📰 Company Negative News

• DII holding declined by 0.23%, signaling reduced domestic institutional interest.

📢 Company Positive News

• Quarterly PAT increased from ₹269 Cr. to ₹302 Cr., showing earnings growth.

🏭 Industry

• Pharmaceutical sector benefits from global demand and regulatory tailwinds but faces pricing pressure.
• Industry P/E of 33.1 reflects moderate optimism across peers.

🧾 Conclusion

• GLAND offers a cautious intraday setup with strong fundamentals and volume support.
• Best suited for scalping trades near support with tight stop loss and defined exit levels.
• Monitor RSI and MACD for signs of reversal before entering aggressively.

I can track GLAND’s live RSI and MACD to notify you when momentum shifts toward a bullish setup.